Mechanisms of Disease: the hypoxic tubular hypothesis of diabetic nephropathy

被引:154
作者
Singh, Dhruv K. [1 ]
Winocour, Peter [2 ]
Farrington, Ken [1 ]
机构
[1] Lister Hosp, Renal Unit, Stevenage SG1 4AB, Herts, England
[2] Queen Elizabeth II Med Ctr, Welwyn Garden City, Herts, England
来源
NATURE CLINICAL PRACTICE NEPHROLOGY | 2008年 / 4卷 / 04期
关键词
1,25-dihydroxyvitamin D3; chronic hypoxia; diabetic nephropathy; erythropoietin; tubule;
D O I
10.1038/ncpneph0757
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Diabetic nephropathy is traditionally considered to be a primarily glomerular disease, although this contention has recently been challenged. Early tubular injury has been reported in patients with diabetes mellitus whose glomerular function is intact. Chronic hypoxia of the tubulointerstitium has been recognized as a mechanism of progression that is common to many renal diseases. The hypoxic milieu in early-stage diabetic nephropathy is aggravated by manifestations of chronic hyperglycemia-abnormalities of red blood cells, oxidative stress, sympathetic denervation of the kidney due to autonomic neuropathy, and diabetes-mellitus-induced tubular apoptosis; as such, tubulointerstitial hypoxia in diabetes mellitus might be an important early event. Chronic hypoxia could have a dominant pathogenic role in diabetic nephropathy, not only in promoting progression but also during initiation of the condition. Early loss of tubular and peritubular cells reduces production of 1,25-dihydroxyvitamin D3 and erythropoietin, which, together with dysfunction of their receptors caused by the diabetic state, diminishes the local trophic effects of the hormones. This diminution could further compromise the functional and structural integrity of the parenchyma and contribute to the gradual decline of renal function.
引用
收藏
页码:216 / 226
页数:11
相关论文
共 159 条
[31]   Pathogenesis, prevention, and treatment of diabetic nephropathy [J].
Cooper, ME .
LANCET, 1998, 352 (9123) :213-219
[32]   Anemia and diabetes in the absence of nephropathy [J].
Craig, KJ ;
Williams, JD ;
Riley, SG ;
Smith, H ;
Owens, DR ;
Worthing, D ;
Cavill, I ;
Phillips, AO .
DIABETES CARE, 2005, 28 (05) :1118-1123
[33]  
DALLAVESTRA M, 2000, DIABETES METAB S, V26, pS8
[34]  
DIKOW R, 2002, NEPHROL DIAL TRAN S1, V17, pS67
[35]  
DITZEL J, 1989, DIABETES METAB, V15, P292
[36]   Normalization of hemoglobin level in patients with chronic kidney disease and anemia [J].
Drueke, Tilman B. ;
Locatelli, Francesco ;
Clyne, Naomi ;
Eckardt, Kai-Uwe ;
Macdougall, Iain C. ;
Tsakiris, Dimitrios ;
Burger, Hans-Ulrich ;
Scherhag, Armin .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (20) :2071-2084
[37]   Aldose reductase and the role of the polyol pathway in diabetic nephropathy [J].
Dunlop, M .
KIDNEY INTERNATIONAL, 2000, 58 :S3-S12
[38]   Role of hypoxia in the pathogenesis of renal disease [J].
Eckardt, KU ;
Rosenberger, C ;
Jürgensen, JS ;
Wiesener, MS .
BLOOD PURIFICATION, 2003, 21 (03) :253-257
[39]   DISTRIBUTION OF ERYTHROPOIETIN PRODUCING CELLS IN RAT KIDNEYS DURING HYPOXIC HYPOXIA [J].
ECKARDT, KU ;
KOURY, ST ;
TAN, CC ;
SCHUSTER, SJ ;
KAISSLING, B ;
RATCLIFFE, PJ ;
KURTZ, A .
KIDNEY INTERNATIONAL, 1993, 43 (04) :815-823
[40]  
EPSTEIN FH, 1994, ANN NY ACAD SCI, V718, P72